Taysha Gene Therapies, Inc. TSHA Other Investing
Other Investing at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.
The official record: Taysha Gene Therapies, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s other investing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s other investing?
- Taysha Gene Therapies, Inc. (TSHA) reported other investing of -$3K in Q4 2025.
- How has Taysha Gene Therapies, Inc.'s other investing changed year-over-year?
- Taysha Gene Therapies, Inc.'s other investing decreased by 9.1% year-over-year, from -$2.75K to -$3K.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s other investing?
- Over 2 years (2022 to 2025), Taysha Gene Therapies, Inc.'s other investing has grown at a 48.2% compound annual growth rate (CAGR), from $61K to -$134K.
- What does other investing mean?
- Miscellaneous investing cash flows not classified in specific line items.